No abstract available
MeSH terms
- COVID-19 / prevention & control*
- COVID-19 Vaccines / adverse effects*
- Clinical Trials, Phase IV as Topic
- Drug Development
- Humans
- Influenza A Virus, H1N1 Subtype
- Influenza Vaccines
- Product Surveillance, Postmarketing*
- Public Health Surveillance
- United States
Substances
- COVID-19 Vaccines
- Influenza Vaccines